Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
about
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisThe "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?What happens to cardiovascular system behind the undetectable level of HIV viremia?Vascular endothelial dysfunction and pharmacological treatmentUnresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritisEffect of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor on disease activity in patients with rheumatoid arthritis: a meta-analysisAngiotensin II in inflammation, immunity and rheumatoid arthritisPediatric Statin Administration: Navigating a Frontier with Limited DataRegulation of Adaptive Immunity in Health and Disease by Cholesterol MetabolismOngoing clinical trials of the pleiotropic effects of statinsTumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesStatin therapy and autoimmune disease: from protein prenylation to immunomodulationIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesImproved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR TrialLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewStatin use in giant cell arteritis: a retrospective study.Statin use and mortality in rheumatoid arthritis: a general population-based cohort studyPersistence with statins and onset of rheumatoid arthritis: a population-based cohort study.Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims databaseEffects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentEndothelial dysfunction in chronic inflammatory diseasesSimvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis.Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis.The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction.Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice.Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degenerationInhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts.Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis.LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective studyPrehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.
P2860
Q21144329-4E986DD5-C076-41DC-A988-A6F62CDD18A6Q24242787-C38BC485-D1E5-4182-9A58-6BF5F7F9A755Q24796000-B03AB7D3-A0E3-4C20-A6BF-CB11E750891FQ24804153-080BA942-B622-4109-9FFB-22AD5D9D788EQ26749024-A0F911A8-8299-4050-83E4-FBC9A11458ACQ26774561-EB770D71-D8DD-4F7F-8C2C-CB71556609A5Q26822912-CAA87E94-8A0D-4AD6-ADF3-A6E75282BE04Q26851763-7D801EBF-39CB-4469-B48E-6EFB4EA999CAQ26991828-9FA747D6-DD90-49D8-9599-E99AF698A10FQ28068014-EBECDD4C-76D8-439B-9D33-8A51BF2A1C39Q28083961-6654FAFF-2257-4A3F-851B-66D56E105924Q28219321-987A5411-868E-467F-86F8-30B21E3FFF22Q28219857-EFC79CAE-B4F3-4300-A10D-D38BE0EFAC97Q28236647-64DB2D73-81A8-4C4C-980E-D67A7C247171Q28388335-B66CCB61-8BD0-4232-8255-F2E1CD209A53Q28731029-9A91975C-482C-46C6-A578-470CE93D8550Q28742007-AC085AFC-B379-4EB6-8D94-FC19BAEB3DF0Q28755180-1C7E8DEC-2FDE-4CD5-A7A3-4088DE511E50Q33576127-D2412ACD-ED6A-437D-B387-DE32AE1B2667Q33588462-12C7253A-0DF0-4912-A11B-85063CFFA171Q33691624-B93A730B-33BE-4B32-B391-D8E3D2DD7058Q33696612-2EA267F6-877B-433E-8E28-A05C5F923EE6Q33865223-3CED3448-7D46-4950-8D9B-C2722945C151Q33943374-64AEE917-BD5E-494C-9828-8B1697C04E0BQ34072179-D125157B-1F6C-49AF-8A43-9DB4BC89C2BCQ34101296-2747A6EA-24B9-4E1F-AD55-822DE16D7332Q34149748-4E4EE346-C6C9-41DB-A8B8-ED8761D8E322Q34167653-CB259370-6C3B-4D9E-8997-987509D973E2Q34238357-EB000AB1-9B75-41EA-88D4-AA14F7A0578EQ34344584-C2778E5A-0EE4-492C-BC19-1CBE4FB376CBQ34398263-6813B5B1-ECC9-4ABD-AE63-49EE1A7C2939Q34448370-DB7F3448-360A-4F14-A21A-7B6F3ACCF364Q34457410-F89F87C8-2129-4419-944E-D3F711C7D528Q34519891-9C232B2A-FFD2-4321-896B-10AD35CADADEQ34530587-A28FB24C-1B5C-45E2-BB0C-A841B1A0C6E7Q34538139-B800B928-937E-4D10-A252-98D13850E03AQ34612901-B22EDDAF-3478-417A-9151-4B02470CB4B2Q34776189-FE62B4E9-62BF-44FA-829F-77FB711DEEEFQ34901953-6D312AF6-217E-4825-9CAC-BA96189780D9Q35007498-BA733756-68E7-42F5-9CDC-ACCDCCEF1DFF
P2860
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@ast
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@en
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@nl
type
label
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@ast
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@en
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@nl
prefLabel
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@ast
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@en
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@nl
P2093
P1433
P1476
Trial of Atorvastatin in Rheum ...... ised placebo-controlled trial.
@en
P2093
David W McCarey
Hilary A Capell
Olga Scherbakov
Rajan Madhok
Rosie Hampson
P304
P356
10.1016/S0140-6736(04)16449-0
P407
P577
2004-06-01T00:00:00Z